US FTC to sue drug middlemen over insulin prices, WSJ reports
(Reuters) -The U.S. Federal Trade Commission is planning to sue UnitedHealth, Cigna and CVS Health – the three largest pharmacy-benefit managers – over their tactics for negotiating prices for drugs including insulin, the Wall Street Journal reported on Wednesday. Pharmacy benefit managers, or PBMs, act as middlemen between drug companies and consumers. They negotiate fees and…
